Synopsis of recent research by authors named "Ahmad Niaj"
- Recent research by Ahmad Niaj focuses on the systemic evaluation of pharmaceutical interventions aimed at reducing cardiovascular risk, particularly through the use of PCSK9 inhibitors in patients with acute coronary syndrome, which shows promising results in lowering LDL cholesterol levels and preventing cardiovascular events.
- Niaj also explores the role of Bempedoic Acid in conjunction with existing therapies to manage low-density lipoprotein cholesterol in patients with coronary artery disease, underscoring its importance in addressing one of the leading causes of mortality worldwide.
- Additionally, his research addresses novel treatments for cystic fibrosis and the relationship between migraines and strokes, providing valuable insights into both the efficacy of new therapies like Trikafta and the hidden risks associated with migraines in women.
